Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
IST:SELEC'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.05 Max: 0.34
Current: 0.18
During the past 13 years, the highest Debt-to-Equity Ratio of Selcuk Ecza Deposu Ticaret venayi AS was 0.34. The lowest was 0.01. And the median was 0.05.
IST:SELEC's Debt-to-Equity is ranked better than 71.72% of 99
companies
in the Medical Distribution industry
Industry Median: 0.48
vs IST:SELEC: 0.18
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Selcuk Ecza Deposu Ticaret venayi AS Debt-to-Equity Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Debt-to-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Debt-to-Equity Chart
IST:SELEC vs MCK, COR, CAH: Debt-to-Equity Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Debt-to-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Debt-to-Equity of 0.18 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. This is 260% above median its historical median of 0.05. Over the past decade, Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity has ranged from 0.01 to 0.34. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #28 out of 99 companies in the Medical Distribution industry, placing it in the top 28.3%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Debt-to-Equity of 0.18 is 260% above median its 10-year median of 0.05. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 0.34. The Medical Distribution industry median Debt-to-Equity is 0.48. Selcuk Ecza Deposu Ticaret venayi AS's value of 0.18 is 62.5% below this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #28 out of 99 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Debt-to-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #28 out of 99 companies for Debt-to-Equity. This puts Selcuk Ecza Deposu Ticaret venayi AS in the upper half of its industry. The industry median Debt-to-Equity is 0.48. Selcuk Ecza Deposu Ticaret venayi AS's value of 0.18 is 62.5% below this benchmark. Historically, Selcuk Ecza Deposu Ticaret venayi AS's own Debt-to-Equity has ranged from 0.01 to 0.34 over the past decade. While the company's 10-year median is 0.05 vs. the industry median of 0.48, Selcuk Ecza Deposu Ticaret venayi AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Distribution company?
The median Debt-to-Equity among Medical Distribution companies is 0.48, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current Debt-to-Equity of 0.18 is 62.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Debt-to-Equity is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Debt-to-Equity is 0.18, which is 260% above median its own 10-year median of 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺90.05, compared to a current price of ₺220.60 — trading 145% above its estimated fair value. The current Debt-to-Equity is 0.18, which is 260% above median its 10-year median of 0.05 and 62.5% below the Medical Distribution industry median of 0.48. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Debt-to-Equity is 0.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺220.60 is trading 145% above its estimated GF Value™ of ₺90.05.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Debt-to-Equity: 0.18 (260% above median its 10-year median of 0.05)
GF Value™: ₺90.05 vs. price of ₺220.60 (145% above fair value)
Industry Position: 62.5% below the Medical Distribution median (#28 of 99)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
80GF Score
Get the complete analysis for IST:SELEC
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
